Mestag Therapeutics

Mestag Therapeutics is a biotech company in London, United Kingdom, founded in 2020. It has raised $85.0M across 3 rounds, most recently a $40.0M Growth Equity in March 2026.

Mestag Therapeutics » Signaling a new era in immunotherapy

Headquarters
London
Employees
11–50
Founded
2020
Business Model
B2B
Total Funding
$85.0M
Last Round
$40.0M Growth EquityMar 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

Mestag Therapeutics develops first-in-class antibody therapies that target fibroblast immunology for cancer and inflammatory diseases. The company is advancing treatments that harness activated fibroblasts to restore proper immune function for patients who do not benefit from current options. Its portfolio includes MST-0312, a bispecific antibody designed to generate a specialized immune response against cancer cells by forming tertiary lymphoid structures in solid tumors and progressing toward a first clinical trial, plus the M402 agonist-antibody program aimed at inflammatory diseases such as rheumatoid arthritis, IBD, and lupus.

Summary

It lists 11–50 employees. It has raised $85.0M in total across 3 rounds, most recently a $40.0M Growth Equity round in Mar 2026. Investors include Forbion Capital Partners, SV Health Investors and Johnson & Johnson Innovation.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityMar 2026
$40.0M

Sign up to see all 3 events

Funding: Seed through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mestag Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mestag-therapeutics"><img src="https://indexed.vc/api/badge/company/mestag-therapeutics" alt="Mestag Therapeutics on Indexed.vc" width="260" height="76" /></a>